Literature DB >> 28973950

RIPK1 promotes inflammation and β-amyloid accumulation in Alzheimer's disease.

David C Rubinsztein1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28973950      PMCID： PMC5642738          DOI： 10.1073/pnas.1715241114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  14 in total

1.  Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.

Authors:  Nicole Maphis; Guixiang Xu; Olga N Kokiko-Cochran; Shanya Jiang; Astrid Cardona; Richard M Ransohoff; Bruce T Lamb; Kiran Bhaskar
Journal:  Brain       Date:  2015-03-31       Impact factor: 13.501

2.  Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits.

Authors:  Dun-Sheng Yang; Philip Stavrides; Panaiyur S Mohan; Susmita Kaushik; Asok Kumar; Masuo Ohno; Stephen D Schmidt; Daniel Wesson; Urmi Bandyopadhyay; Ying Jiang; Monika Pawlik; Corrinne M Peterhoff; Austin J Yang; Donald A Wilson; Peter St George-Hyslop; David Westaway; Paul M Mathews; Efrat Levy; Ana M Cuervo; Ralph A Nixon
Journal:  Brain       Date:  2011-01       Impact factor: 13.501

3.  Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury.

Authors:  Alexei Degterev; Zhihong Huang; Michael Boyce; Yaqiao Li; Prakash Jagtap; Noboru Mizushima; Gregory D Cuny; Timothy J Mitchison; Michael A Moskowitz; Junying Yuan
Journal:  Nat Chem Biol       Date:  2005-05-29       Impact factor: 15.040

Review 4.  Untangling Genetic Risk for Alzheimer's Disease.

Authors:  Anna A Pimenova; Towfique Raj; Alison M Goate
Journal:  Biol Psychiatry       Date:  2017-05-22       Impact factor: 13.382

Review 5.  Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis.

Authors:  Kelby W Wegner; Danish Saleh; Alexei Degterev
Journal:  Trends Pharmacol Sci       Date:  2017-01-23       Impact factor: 14.819

Review 6.  Microglia in Alzheimer's disease.

Authors:  Heela Sarlus; Michael T Heneka
Journal:  J Clin Invest       Date:  2017-09-01       Impact factor: 14.808

7.  2016 Alzheimer's disease facts and figures.

Authors: 
Journal:  Alzheimers Dement       Date:  2016-04       Impact factor: 21.566

8.  RIPK1 mediates a disease-associated microglial response in Alzheimer's disease.

Authors:  Dimitry Ofengeim; Sonia Mazzitelli; Yasushi Ito; Judy Park DeWitt; Lauren Mifflin; Chengyu Zou; Sudeshna Das; Xian Adiconis; Hongbo Chen; Hong Zhu; Michelle A Kelliher; Joshua Z Levin; Junying Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-13       Impact factor: 11.205

9.  Loss of tau rescues inflammation-mediated neurodegeneration.

Authors:  Nicole Maphis; Guixiang Xu; Olga N Kokiko-Cochran; Astrid E Cardona; Richard M Ransohoff; Bruce T Lamb; Kiran Bhaskar
Journal:  Front Neurosci       Date:  2015-06-03       Impact factor: 4.677

10.  Cystatin F is a biomarker of prion pathogenesis in mice.

Authors:  Mario Nuvolone; Nicolas Schmid; Gino Miele; Silvia Sorce; Rita Moos; Christian Schori; Roger R Beerli; Monika Bauer; Philippe Saudan; Klaus Dietmeier; Ingolf Lachmann; Michael Linnebank; Roland Martin; Ulf Kallweit; Veronika Kana; Elisabeth J Rushing; Herbert Budka; Adriano Aguzzi
Journal:  PLoS One       Date:  2017-02-08       Impact factor: 3.240
View more
  5 in total

1.  Overexpressed microRNA-494 represses RIPK1 to attenuate hippocampal neuron injury in epilepsy rats by inactivating the NF-κB signaling pathway.

Authors:  Yinbao Qi; Ruobing Qian; Li Jia; Xiaorui Fei; Dong Zhang; Yiming Zhang; Sen Jiang; Xianming Fu
Journal:  Cell Cycle       Date:  2020-04-19       Impact factor: 4.534

2.  IKKβ Alleviates Neuron Injury in Alzheimer's Disease via Regulating Autophagy and RIPK1-Mediated Necroptosis.

Authors:  Wei Wang; Xunhu Gu; Zhijuan Cheng; Xiaoqing Lu; Shuhua Xie; Xu Liu
Journal:  Mol Neurobiol       Date:  2022-01-27       Impact factor: 5.590

3.  O-GlcNAcylation ameliorates the pathological manifestations of Alzheimer's disease by inhibiting necroptosis.

Authors:  Jinsu Park; Hee-Jin Ha; Eun Seon Chung; Seung Hyun Baek; Yoonsuk Cho; Hark Kyun Kim; Jihoon Han; Jae Hoon Sul; Jeongmi Lee; Eunae Kim; Junsik Kim; Yong Ryoul Yang; Mikyoung Park; Sung Hyun Kim; Thiruma V Arumugam; Hyemin Jang; Sang Won Seo; Pann-Ghill Suh; Dong-Gyu Jo
Journal:  Sci Adv       Date:  2021-01-13       Impact factor: 14.136

4.  Inhibiting RIPK1 Limits Neuroinflammation and Alleviates Postoperative Cognitive Impairments in D-Galactose-Induced Aged Mice.

Authors:  Shangchun Duan; Xueqin Wang; Gong Chen; Chengxuan Quan; Shuangquan Qu; Jianbin Tong
Journal:  Front Behav Neurosci       Date:  2018-07-10       Impact factor: 3.558

Review 5.  Positive Feedback Loops in Alzheimer's Disease: The Alzheimer's Feedback Hypothesis.

Authors:  Andrew J Doig
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.